The impact of comorbidities on therapy-optimization and their prognostics role among hospitalized patients with heart failure with reduced ejection fraction

31 August 2024 (16:25 - 16:35)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Balazs Muk

Gottsegen National Cardiovascular Center, Budapest (Hungary)

4 More presentations in this session

Presentation thumbnail

Heart failure and advanced chronic kidney disease: differences in characteristics, treatment and outcomes in patients with glomerular filtration rate greater or less than 30 ml/minute/m2

Doctor A. Recio Mayoral (Seville, ES)

Abstract Slides Video

Presentation thumbnail

Chronic kidney disease in patients with heart failure in German primary care practices: the InspeCKD study

Professor T. Frese (Halle, DE)

Abstract Slides Video

Presentation thumbnail

Validation of existing risk scores for worsening renal function in patients with newly diagnosed heart failure: a longitudinal population cohort study

Professor C. Lang (Dundee, GB)

Abstract Slides Video

Presentation thumbnail

Kidney status and events preceding death in heart failure: A real world data study on 18,456 patients with heart failure

Mrs D. Zahir (Copenhagen, DK)

Abstract Slides Video

Access the full session

Session thumbnail

Heart and kidney in heart failure: no end to the dangerous liaison

The Event

Event poster

ESC Congress 2024

31 August 2024 16:25 CET

You may be interested in

Congress Session

Comorbidities and heart failure therapies

Congress Presentation

Comorbidities as barriers to guidelines implementation

Congress Presentation

Initiation and titration of prognostic drug therapy during hospitalization for acute decompensation of heart failure with reduced ejection fraction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources